Thomas McKnight
Family Medicine · Fremont, NENPI 1679587778
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 74 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 16.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $740 and has fallen 96.8% since, to $24 in 2023.
Across 74 payments — averaging $13.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$170
- Pfizer$137
- Johnson & Johnson$97
- Amarin Pharma, Inc.$90
- Sanofi-aventis U.S. LLC$60
- AbbVie$58
- plus $413 from 19 others
Across 18 payments — averaging $1598.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$29K
What the payments were for
- Food & beverage$1,025100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 9 | $170 |
| Pfizer | 14 | $137 |
| Johnson & Johnson | 7 | $97 |
| Amarin Pharma, Inc. | 5 | $90 |
| Sanofi-aventis U.S. LLC | 4 | $60 |
| AbbVie(2 entities) | 4 | $58 |
| Novo Nordisk | 4 | $52 |
| Novartis | 3 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $32 |
| Sunovion Pharmaceuticals Inc. | 2 | $28 |
| Boehringer Ingelheim | 2 | $28 |
| Lilly USA, LLC | 2 | $27 |
| Arbor Pharmaceuticals, Inc. | 2 | $24 |
| Aroa Biosurgery Incorporated | 1 | $24 |
| AstraZeneca | 2 | $22 |
| Grifols USA, LLC | 1 | $17 |
| Scilex Pharmaceuticals Inc. | 1 | $16 |
| Valeritas, Inc. | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Astellas Pharma US Inc | 1 | $12 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
| Therapeuticsmd, Inc. | 1 | $11 |
| Neurocrine Biosciences, Inc. | 1 | $11 |
| Merck | 1 | $11 |
How this compares
$1,025 in reported general payments places this provider in the 60th percentile of 981 family medicine providers in Nebraska.
Other family medicine in Fremont
- Andrea VermaasFremont$11K
- Michael IsraelLincoln$375K
- Francisco DozonNorfolk$238K
- Randy KohlLincoln$67K
- James OmelGrand Island$67K
- Gerard StanleyOmaha$50K
- Jared KramerSt Paul$41K
- Randolph WaldmanHebron$27K
- Brian FinleyBellevue$20K
- William FitzgibbonsElkhorn$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.